IPO

Gaudium IVF & Women Health Limited IPO

Mainboard

Offer Date: Feb 20, 2026 - Feb 24, 2026

₹ NaN /N/A Shares

20 Feb, 2026

Open Date

24 Feb, 2026

Close Date

25 Feb, 2026

Allotment Date

27 Feb, 2026

Listing Date
Gaudium IVF & Women Health IPO Issue Details
  • Issue Price ₹N/A per equity share
  • Face Value ₹5 Per Equity Share
  • Issue Price N/A
  • Listing at BSE, NSE
  • Lead Manager Sarthi Capital Advisors Pvt.Ltd.
  • Registrar Bigshare Services Pvt.Ltd.
Gaudium IVF & Women Health IPO Details
  • Retail Portion 35%
Gaudium IVF & Women Health IPO Documents
Gaudium IVF & Women Health IPO Details


The IPO of Gaudium IVF & Women Health is priced at ₹N/A per equity share, which has a face value of ₹5 Per Equity Share each, IPO bidding starts from Feb 20, 2026 and ends on Feb 24, 2026. The allotment for Gaudium IVF & Women Health IPO will be finalized on Feb 25, 2026. Gaudium IVF & Women Health IPO will be listed on BSE, NSE, with a tentative listing date fixed as Feb 27, 2026. The company shall list its equity shares on the BSE, NSE. Bigshare Services Pvt.Ltd. is the registrar of the issue.

The book-running lead manager for the IPO is/are Sarthi Capital Advisors Pvt.Ltd..


The Gaudium IVF & Women Health IPO sets its price band at N/A for each share. A single application for Gaudium IVF & Women Health Limited IPO must contain at least N/A shares.

Read More
Gaudium IVF & Women Health Valuations
EPS Pre IPO ₹/-
EPS Post IPO ₹/-
Market Cap. Cr.
Gaudium IVF & Women Health Company Financials
In Crs.
In Cr.
31-Mar-25 31-Mar-24 31-Mar-23
Assets 88.51 51.01 36.63
Revenue 70.96 48.15 44.26
Profit After Tax 19.13 10.32 13.53
Net Worth 46.30 26.99 22.73
Reserves & Surplus 15.60 26.00 21.74
Total Borrowing 18.93 15.73 9.78
About Gaudium IVF & Women Health Company

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.

The company has more than thirty locations. These include seven hubs (centres) and twenty-eight spokes. The strategic alliance between the organization and Infertility Experts, referred to as Spokes, was forged in order to meet the mutual goal of spreading awareness about Assisted Reproductive Technology or ART and In Vitro Fertilization or IVF treatments.The patients come from various countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has hubs in Delhi, two Janakpuri and Kailash Colony; Mumbai; Khar West; Ludhiana; Srinagar; Patna; and Bangalore, covering all important locations across the subcontinent.
This company offers a range of specialized fertility services: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and ovulation induction. Our treatments are specifically directed for a variety of infertility conditions in both males and females. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis and high-risk pregnancy management for women with complex fertility history or health conditions.
These facilities cover a wide scope of male infertility treatments, right from advanced sperm retrieval techniques.

Read More
Gaudium IVF & Women Health - Promoter(s)

Dr. Manika Khanna

Dr. Peeyush Khanna

Vishad Khanna

Pre Issue Share Holding : N/A%

Post Issue Share Holding : N/A%

Gaudium IVF & Women Health IPO - Issue Objectives
1

Funding capital expenditure towards establishment of New IVF Centers of the Company

2

Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company

3

General Corporate Purpose

Contact Details

Gaudium IVF & Women Health

B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058

011-4885 8585

compliance@gaudiumivfcentre.com

https://www.gaudiumivfcentre.com/

Registrar Contact Details

Bigshare Services Pvt Ltd

+91-22-6263 8200

ipo@bigshareonline.com

https://ipo.bigshareonline.com/ipo_status.html